AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 191 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $30,000 | -57.1% | 13,106 | -29.0% | 0.00% | -50.0% |
| Q2 2021 | $70,000 | +1300.0% | 18,451 | +1142.5% | 0.00% | – |
| Q1 2021 | $5,000 | -66.7% | 1,485 | -71.7% | 0.00% | -100.0% |
| Q4 2020 | $15,000 | +275.0% | 5,240 | +248.2% | 0.00% | – |
| Q3 2020 | $4,000 | -73.3% | 1,505 | -25.1% | 0.00% | -100.0% |
| Q1 2020 | $15,000 | +114.3% | 2,009 | +93.2% | 0.01% | +250.0% |
| Q4 2019 | $7,000 | +600.0% | 1,040 | +612.3% | 0.00% | – |
| Q3 2019 | $1,000 | -92.3% | 146 | -94.8% | 0.00% | -100.0% |
| Q2 2019 | $13,000 | +160.0% | 2,786 | +497.9% | 0.00% | +100.0% |
| Q2 2018 | $5,000 | -89.1% | 466 | -90.4% | 0.00% | -91.7% |
| Q1 2018 | $46,000 | -16.4% | 4,849 | +26.7% | 0.02% | -57.9% |
| Q2 2017 | $55,000 | – | 3,828 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
| DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
| Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
| Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
| Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
| Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
| Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
| Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
| Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |